IP Library Assignment 055815/0597
Patent Assignment
Reel/Frame 055815/0597

Assignment of Assignor's Interest

Recorded: 2021-04-02 Pages: 26
Assignor
VELOXIS PHARMACEUTICALS A/S
Executed: 2020-12-30
Assignee
VELOXIS PHARMACEUTICALS INC.
1001 WINSTEAD DRIVE, SUITE 310, CARY, NORTH CAROLINA, 27513
Covered Properties (36)
Porous Tablets As Carriers For Liquid Formulations
Application: 14/635,950 →
Publication: US 2015/0164812
Modified Release Compositions Comprising Tacrolimus
Application: 15/677,938 →
Publication: US 2018/0228779
Stabilized Tacrolimus Composition
Application: 16/188,805 →
Publication: US 2019/0282504
Solid Dispersions Comprising Tacrolimus
Application: 16/657,368 →
Publication: US 2020/0289478
Regimen for Suppressing Organ Rejection
Application: 16/678,527 →
Publication: US 2020/0268721
Tacrolimus For Improved Treatment Of Transplant Patients
Application: 17/085,291 →
Publication: US 2021/0046054
Tacrolimus For Improved Treatment Of Transplant Patients
Application: 17/085,379 →
Publication: US 2021/0046055
Tablet Comprising a Fibrate
Patent: 9,173,847 →
Application: 11/449,918 →
Publication: US 2007/0026062
Controlled Agglomeration
Patent: 7,217,431 →
Application: 10/482,558 →
Publication: US 2005/0008706
Controlled Agglomeration
Patent: 8,535,799 →
Application: 11/711,965 →
Publication: US 2007/0275074
Modified Release Compositions Comprising Tacrolimus
Patent: 8,591,946 →
Application: 10/569,862 →
Publication: US 2006/0287352
Solid Dispersions Comprising Tacrolimus
Patent: 7,994,214 →
Application: 10/569,863 →
Publication: US 2010/0008984
Self-Cleaning Spray Nozzle
Patent: 7,252,247 →
Application: 10/519,992 →
Publication: US 2005/0242209
Solid Dosage Form Comprising a Fibrate
Patent: 7,658,944 →
Application: 10/513,807 →
Publication: US 2006/0110444
Solid Dosage Form Comprising a Fibrate
Patent: 8,124,125 →
Application: 12/642,563 →
Publication: US 2010/0323008
Tacrolimus for Improved Treatment of Transplant Patients
Patent: 8,685,998 →
Application: 12/499,034 →
Publication: US 2010/0105717
Stabilized Tacrolimus Composition
Patent: 9,549,918 →
Application: 13/029,304 →
Publication: US 2014/0038998
Modified release compositions comprising tacrolimus
Patent: 8,617,599 →
Application: 13/167,095 →
Publication: US 2011/0251231
Modified Release Compositions Comprising Tacrolimus
Patent: 8,623,410 →
Application: 13/167,160 →
Publication: US 2011/0250277
Modified Release Compositions Comprising Tacrolimus
Patent: 8,586,084 →
Application: 13/167,281 →
Publication: US 2011/0251232
Modified release compositions comprising tacrolimus
Patent: 8,623,411 →
Application: 13/167,334 →
Publication: US 2011/0256190
Tacrolimus For Improved Treatment Of Transplant Patients
Patent: 8,664,239 →
Application: 13/167,420 →
Publication: US 2012/0029009
Solid dispersions comprising tacrolimus
Patent: 8,486,993 →
Application: 13/178,280 →
Publication: US 2011/0263632
Solid Dosage Form Comprising a Fibrate
Patent: 8,481,078 →
Application: 13/315,030 →
Publication: US 2012/0195965
Controlled Agglomeration
Patent: 9,295,653 →
Application: 13/969,300 →
Publication: US 2014/0086991
Modified Release Compositions Comprising Tacrolimus
Patent: 8,889,185 →
Application: 14/079,414 →
Publication: US 2014/0073665
Modified Release Compositions Comprising Tacrolimus
Patent: 9,161,907 →
Application: 14/079,443 →
Publication: US 2014/0066473
Modified Release Compositions Comprising Tacrolimus
Patent: 8,889,186 →
Application: 14/079,466 →
Publication: US 2014/0065225
Regimen for Suppressing Organ Rejection
Patent: 9,168,246 →
Application: 14/317,500 →
Publication: US 2015/0004154
Regimen for Supressing Organ Rejection
Patent: 9,775,834 →
Application: 14/867,773 →
Publication: US 2016/0015692
Modified Release Compositions Comprising Tacrolimus
Patent: 9,757,362 →
Application: 14/855,624 →
Publication: US 2016/0243090
Solid dispersions comprising tacrolimus
Patent: 9,763,920 →
Application: 14/934,908 →
Publication: US 2016/0166551
Tacrolimus For Improved Treatment Of Transplant Patients
Application: 15/041,986 →
Publication: US 2016/0243091
Stabilized Tacrolimus Composition
Application: 15/405,879 →
Publication: US 2017/0119675
Solid Dispersions Comprising Tacrolimus
Application: 15/676,727 →
Publication: US 2018/0214422
Regimen for Suppressing Organ Rejection
Application: 15/682,275 →
Publication: US 2018/0193319
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 26, 2004
From: HOLM, PER; BUUR, ANDERS; ELEMA, MICHIEL ONNE; MOLLGAARD, BIRGITTE
To: LIFECYCLE PHARMA A/S
Reel/Frame 016150/0152 →
Assignment of Assignor's Interest Jan 4, 2005
From: HOLM, PER; NORLING, TOMAS
To: LIFECYCLE PHARMA A/S
Reel/Frame 015553/0926 →
Assignment of Assignor's Interest Jan 4, 2005
From: HOLM, PER; NIELSEN, ELO
To: LIFECYCLE PHARMA A/S
Reel/Frame 016797/0813 →
Assignment of Assignor's Interest Jun 9, 2006
From: HOLM, PER; NORLING, TOMAS
To: LIFECYCLE PHARMA A/S
Reel/Frame 017754/0875 →
Assignment of Assignor's Interest Jun 9, 2006
From: HOLM, PER; NORLING, TOMAS
To: LIFECYCLE PHARMA A/S
Reel/Frame 017760/0203 →
Assignment of Assignor's Interest Sep 19, 2006
From: HOLM, PER; NORLING, TOMAS
To: LIFECYCLE PHARMA A/S
Reel/Frame 018275/0977 →
License of Certain Rights Sep 3, 2008
From: LIFECYCLE PHARMA A/S
To: COWEN HEALTHCARE ROYALTY PARTNERS, L.P.
Reel/Frame 021511/0624 →
License of Certain Rights Sep 4, 2008
From: LIFECYCLE PHARMA A/S
To: COWEN HEALTHCARE ROYALTY PARTNERS, L.P.
Reel/Frame 021518/0369 →
Assignment of Assignor's Interest Nov 20, 2009
From: GORDON, ROBERT D.; HOLM, PER; LADEMANN, ANNE-MARIE
To: LIFECYCLE PHARMA A/S
Reel/Frame 023548/0350 →
Assignment of Assignor's Interest Dec 9, 2009
From: NORLING, TOMAS
To: LIFECYCLE PHARMA A/S
Reel/Frame 023626/0135 →
Assignment of Assignor's Interest Mar 25, 2011
From: SKAK, NIKOLAJ; HANSEN, LISELOTTE
To: LIFECYCLE PHARMA A/S
Reel/Frame 026024/0570 →
Change of Name Jul 15, 2011
From: LIFECYCLE PHARMA A/S
To: VELOXIS PHARMACEUTICALS A/S
Reel/Frame 026598/0929 →
Assignment of Assignor's Interest Oct 2, 2013
From: HOLM, PER
To: VELOXIS PHARMACEUTICALS A/S
Reel/Frame 031327/0467 →
Change of Address Oct 2, 2013
From: VELOXIS PHARMACEUTICALS A/S
To: VELOXIS PHARMACEUTICALS A/S
Reel/Frame 031333/0647 →
Change of Address Dec 11, 2013
From: VELOXIS PHARMACEUTICALS A/S
To: VELOXIS PHARMACEUTICALS A/S
Reel/Frame 031794/0562 →
Change of Address Jan 16, 2014
From: VELOXIS PHARMACEUTICALS A/S
To: VELOXIS PHARMACEUTICALS A/S
Reel/Frame 032069/0221 →
Security Interest Apr 12, 2016
From: VELOXIS PHARMACEUTICALS A/S
To: NOVO A/S; LUNDBECKFOND INVEST A/S
Reel/Frame 038256/0318 →
Security Interest Feb 15, 2018
From: VELOXIS PHARMACEUTICALS A/S
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044942/0597 →
Release of Security Interest Mar 2, 2018
From: LUNDBECKFOND INVEST A/S; NOVO A/S
To: VELOXIS PHARMACEUTICALS A/S
Reel/Frame 045093/0727 →
Release of Security Interest Jan 23, 2020
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: VELOXIS PHARMACEUTICALS A/S
Reel/Frame 051602/0704 →
Assignment of Assignor's Interest Mar 17, 2021
From: VELOXIS PHARMACEUTICALS A/S,
To: VELOXIS PHARMACEUTICALS INC.
Reel/Frame 055613/0695 →
Assignment of Assignor's Interest Mar 25, 2024
From: GORDON, ROBERT D; HOLM, PER; LADEMANN, ANNE-MARIE
To: LIFECYCLE PHARMA A/S
Reel/Frame 066890/0415 →
Assignment of Assignor's Interest Mar 25, 2024
From: NORLING, TOMAS
To: LIFECYCLE PHARMA A/S
Reel/Frame 066890/0463 →
Assignment of Assignor's Interest Mar 25, 2024
From: LIFECYCLE PHARMA A/S
To: VELOXIS PHARMACEUTICALS A/S
Reel/Frame 066894/0286 →
Change of Address Jun 7, 2024
From: VELOXIS PHARMACEUTICALS INC.
To: VELOXIS PHARMACEUTICALS INC.
Reel/Frame 067666/0352 →